Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment

Por Clemens, Andreas, Fraessdorf, Mandy, Friedman, Jeffrey
Publicado em 2013

The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?

Por Kostikas, Konstantinos, Clemens, Andreas, Patalano, Francesco
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria

Por Clemens, Andreas, Noack, Herbert, Brueckmann, Martina, Lip, Gregory Y. H.
Publicado em 2014

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management

Por Hass, Bastian, Pooley, Jayne, Harrington, Adrian E, Clemens, Andreas, Feuring, Martin
Publicado em 2012

Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects

Por Ring, Arne, Rathgen, Karin, Stangier, Joachim, Reilly, Paul, Clemens, Andreas, Friedman, Jeffrey
Publicado em 2013

Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analys...

Por Lee, Sally, Monz, Brigitta U, Clemens, Andreas, Brueckmann, Martina, Lip, Gregory Y H
Publicado em 2012

Pharmacometric Characterization of Dabigatran Hemodialysis

Por Liesenfeld, Karl-Heinz, Staab, Alexander, Härtter, Sebastian, Formella, Stephan, Clemens, Andreas, Lehr, Thorsten
Publicado em 2013

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized cont...

Por Rosencher Nadia, Noack Herbert, Feuring Martin, Clemens Andreas, Friedman Richard J, Eriksson Bengt I
Publicado em 2012-06-01

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized cont...

Por Rosencher, Nadia, Noack, Herbert, Feuring, Martin, Clemens, Andreas, Friedman, Richard J, Eriksson, Bengt I
Publicado em 2012

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

Por Wurnig, Christian, Clemens, Andreas, Rauscher, Helmuth, Kleine, Eva, Feuring, Martin, Windhager, Reinhard, Grohs, Josef
Publicado no Thromb J (2015)

Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records

Por Kolaczynski, Wlodzimierz M., Hankins, Matthew, Ong, Siew H., Richter, Hartmut, Clemens, Andreas, Toussi, Massoud
Publicado no Diabetes Ther (2016)

Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement

Por Dahl, Ola E., Kurth, Andreas A., Rosencher, Nadia, Noack, Herbert, Clemens, Andreas, Eriksson, Bengt I.
Publicado em 2011

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile

Por Clemens, Andreas, van Ryn, Joanne, Sennewald, Regina, Yamamura, Norio, Stangier, Joachim, Feuring, Martin, Härtter, Sebastian
Publicado em 2012

Erratum to: Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery

Por Dahl, Ola E., Kurth, Andreas A., Rosencher, Nadia, Noack, Herbert, Clemens, Andreas, Eriksson, Bengt I.
Publicado em 2012

The Discovery of Dabigatran Etexilate

Por van Ryn, Joanne, Goss, Ashley, Hauel, Norbert, Wienen, Wolfgang, Priepke, Henning, Nar, Herbert, Clemens, Andreas
Publicado em 2013

Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting

Por Rosencher, Nadia, Samama, Charles M., Feuring, Martin, Brueckmann, Martina, Kleine, Eva, Clemens, Andreas, Frostick, Simon
Publicado no Thromb J (2016)

Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes

Por Gallagher, Arlene M, van Staa, Tjeerd P, Murray-Thomas, Tarita, Schoof, Nils, Clemens, Andreas, Ackermann, Diana, Bartels, Dorothee B
Publicado em 2014

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

Por Eriksson, Bengt I., Dahl, Ola E., Rosencher, Nadia, Clemens, Andreas, Hantel, Stefan, Feuring, Martin, Kreuzer, Jörg, Huo, Michael, Friedman, Richard J.
Publicado no Thromb J (2015)

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the m...

Por Marin, Jose M, Beeh, Kai M, Clemens, Andreas, Castellani, Walter, Schaper, Lennart, Saralaya, Dinesh, Gunstone, Anthony, Casamor, Ricard, Kostikas, Konstantinos, Aalamian-Mattheis, Maryam
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial

Por Vogelmeier, Claus F., Gaga, Mina, Aalamian-Mattheis, Maryam, Greulich, Timm, Marin, Jose M., Castellani, Walter, Ninane, Vincent, Lane, Stephen, Nunez, Xavier, Patalano, Francesco, Clemens, Andreas, Kostikas, Konstantinos
Publicado no Respir Res (2017)